Case | HBS Case Collection | 2009 (Revised from original 2006 version)
by Rohit Deshpande and Ricardo Reisen de Pinho
Abbott Labs has reached an impasse with the Brazilian government in negotiations over the pricing of a new anti-AIDS drug, Kaletra. The Brazilian government threatens compulsory licensing unless Abbott drastically reduces the price of Kaletra.
Keywords: Price; Government and Politics; Health Care and Treatment; Health Disorders; Rights; Negotiation; Business and Government Relations; Pharmaceutical Industry; Brazil;
Citation:
Deshpande, Rohit, and Ricardo Reisen de Pinho. "AIDS in Brazil." Harvard Business School Case 506-062, February 2009. (Revised from original February 2006 version.)
View Profile »View Publications »
Article | International Marketing Review | 2013
Achievement Motivation, Strategic Orientations and Business Performance in Entrepreneurial Firms: How Different Are Japanese and American Founders?
Rohit Deshpandé, Amir Grinstein, Elie Ofek and Sang-Hoon Kim
Keywords: motivation; entrepreneurs; Japan;
Case | HBS Case Collection | 2013 (Revised from original 2011 version)
Branding Yoga
Rohit Deshpande, Kerry Herman and Annelena Lobb
Keywords: Brands and Branding; Marketing;
Teaching Note | HBS Case Collection | 2013 (Revised from original 2007 version)
Cipla (TN)
Rohit Deshpande and Aldo Sesia Jr.